It looks like Samsung is also trying to enter the health wearable space, following in the footsteps of Apple and Google. The South Korean tech giant announced that it’s collaborating with Insulet, a leader in tubeless insulin pump technology with its Omnipod® Insulin Management System to develop a Samsung Galaxy smartphone-controlled Omnipod System.
Related How Wearable Devices Are Changing the World of Drug Delivery
“By integrating Samsung smartphones with drug delivery medical devices like Insulet’s Omnipod System, we’ve demonstrated that consumer-based digital health technologies can not only monitor and track one’s condition, but they can enable patient control of medical treatments,” said Dr. David Rhew, Chief Medical Officer and VP/GM for Enterprise Healthcare, Samsung Electronics America. “As chronic conditions like diabetes continue to increase in prevalence across all demographics, integrated partnerships between consumer technology and medical device companies, with support from regulators, will help establish a new paradigm of consumerism in healthcare in which medical care adapts to consumer lifestyle and preference.”
All Samsung mobile devices have the Samsung Knox mobile security platform to protect against cybersecurity risks. Insulet’s FDA-cleared Omnipod DASH System has been designed as an app on a locked-down mobile phone incorporating state-of-the-art security features. The Knox platform complements the Omnipod DASH System security features by verifying the integrity of the Samsung mobile device through a series of security checks starting from the hardware level and extending through the operating system, creating a highly-secure platform. This will allow users to securely operate their Omnipod System from their smartphone.
“Over the last few years, there have been many exciting advancements that allow individuals to experience how phone control could improve their diabetes management,” said Shacey Petrovic, President and Chief Operating Officer. “For us, because we are delivering a life-sustaining drug, it’s critical that we have the highest measures of safety and security in place. We are thrilled to work with Samsung, the global leader in smartphones, to lead the way in offering phone control of an insulin pump in a way that is simple, safe and secure.”
According to the press release, capabilities will be limited to select models of Samsung Galaxy smartphone. The company will share the information on exact model availability at a later date.
